Publications by authors named "YuFei Pan"

Claim this Profile
R
Recurrent lesion distribution after photodynamic therapy for recurrent respiratory papillomatosis.
Yufei Pan, Huili Huang, Ke Wu, Xiao Han, Huiying Hu

Photodiagnosis Photodyn Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAMC2 promotes gallbladder carcinoma metastasis through the TGF-β pathway.
Mengyou Xu, Yuanyuan Zhang, Huibo Feng, Taiyu Shang, Yibin Chen, Yufei Pan

Cancer Cell Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anlotinib monotherapy in recurrent or metastatic nasopharyngeal carcinoma: a multicenter case-series analysis.
Guan-Jie Qin, Yi-Xin Su, Yong Liang, Bin Zhang, Yu-Fei Pan

Radiol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lidocaine potentiates thermal ablation in cholangiocarcinoma by modulating TRPV6-Driven ca/PI3K/AKT/HSF-1 signaling pathway.
Ping-Ping Chen, Yun-Kai Lin, Ming-Xing Xia, Hui-Bo Feng, Yu-Fei Pan

Cancer Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone Disorders.
Yuan Ma, Gubu Amu, Yufei Pan, Hewen Jiang, Sifan Yu

JACS Au· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Influencing Laryngeal Web After Surgery Combined With Photodynamic Therapy in RRP.
Yufei Pan, Huili Huang, Ke Wu, Huiying Hu, Kai Liu

Laryngoscope· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors and a Preoperative Scoring Tool for Arytenoid Dislocation: A Retrospective Study.
Zhipeng Yin, Yufei Pan, Ke Wu, Yuanyuan Lu, Huiying Hu

J Voice· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.
Taiyu Shang, Tianyi Jiang, Jiangqi Tan, Haolin Jiang, Mengyou Xu, Yufei Pan

Signal Transduct Target Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Aminolevulinic acid-mediated photodynamic therapy improves scar healing of laryngeal wounds in rats.
Jing Li, Yuanyuan Lu, Huiying Hu, Xiao Han, Yufei Pan

Lasers Med Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Vascular-Targeting Agents Plus Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients: A Multicenter Clinical Cohort Study.
Guanhong Luo, Jinping Xu, Guanjie Qin, Yixin Su, Yufei Pan

Cancer Control· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D Genome Architecture in Stem Cell Lineage Commitment: from Structural Organization to Precision Regulation.
Yanchi He, Wenrui Li, Lin Li, Ying Yang, Yutong Lu, Yufei Pan

Adv Genet (Hoboken)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleic acid therapeutics for liver diseases: A decade of technological convergence and clinical challenges.
Yufei Pan, Mingyue Pan, Yuanzheng Huang, Baoping Lian, Yutian Feng

ILIVER· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of COVID-19 Vaccination on Treatment-Related Adverse Events and Oncologic Outcomes of Nonmetastatic Nasopharyngeal Carcinoma.
Minglong Liu, Bin Zhang, Yufei Pan, Xiaoping Lin, Guanhong Luo, Yu Pan

Head Neck· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global disease burden of laryngeal cancer attributable to smoking from 1990 to 2021.
Xiao Han, Shanchun Gong, Chao Wang, Yulin Zhang, Yufei Pan

Eur J Cancer Prev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytidinyl/Cationic Lipid Encapsulating Insulin-Like Growth Factor 1 Receptor siRNA for Hepatocellular Carcinoma Therapy.
Yang Pu, Quanxin Wang, Yufei Pan, Xixian Wang, Zhu Guan

Mol Pharm· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA polymerase II subunit 5-mediating protein limits TLR4-induced innate immune activation in macrophages by inhibiting IKKβ/NF-κB signaling during sepsis.
Shu-Jie Pang, Tian-Yi Jiang, Nai-Guo Wang, Xiao-Wen Cui, Hui Wang, Yu-Fei Pan

Cell Commun Signal· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking the SIRPα-CD47 axis promotes macrophage phagocytosis of exosomes derived from visceral adipose tissue and improves inflammation and metabolism in mice.
Yun-Kai Lin, Yu-Fei Pan, Tian-Yi Jiang, Yi-Bin Chen, Tai-Yu Shang

J Biomed Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF2BP1 Enhances Neprilysin mRNA Stability to Promote Proliferation, Invasion, and Angiogenesis in Placental Trophoblasts.
ChengLing Fan, HongXia Zhou, YuFei Pan, Dan Lu

Int J Gen Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying Bevacizumab Efficacy in Recurrent Respiratory Papillomatosis.
Yufei Pan, Yuanyuan Lu, Huili Huang, Chao Wang, Xiao Han

Laryngoscope· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of surgery combined with photodynamic therapy for recurrent respiratory papillomatosis.
Yufei Pan, Chao Wang, Huili Huang, Yuanyuan Lu, Huiying Hu

Am J Otolaryngol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: perspectives from the United States and China.
Wenwang Lang, Qi Ai, Yulong He, Yufei Pan, Qinling Jiang

Int J Clin Pharm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Aptamer-Paclitaxel Conjugates for Tumor Targeted Therapy.
Xinyang Shen, Yuan Ma, Hang Luo, Razack Abdullah, Yufei Pan

Pharmaceutics· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Toripalimab plus anlotinib in postoperative recurrent renal pelvic sarcomatoid urothelial carcinoma.
Xinrong Hu, Lin Deng, Yufei Pan, Guozhen Zhang, Xiaolan Ruan

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy.
Yuan Ma, Huarui Zhang, Xinyang Shen, Xin Yang, Yan Deng, Yufei Pan

Cancer Lett· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROS-Responsive Ferrocenyl Amphiphilic PAMAM Dendrimers for On-Demand Delivery of siRNA Therapeutics to Cancer Cells.
Peng Chen, Zhihui Wang, Xinmo Wang, Junni Gong, Ju Sheng, Yufei Pan

Pharmaceutics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis